KRAS and cancer: Some of the prominent mutated oncogenes in cancers include BRAF, ErbB2, JAK2, KRAS, MYC, and PIK3CA. Mutations in these oncogenes can result in a high reliance of cancer cells on glutamine for survival and proliferation.